Cannabidiol, or CBD, is one of the main cannabinoid components isolated from the Cannabis Sativa plant species. Cannabis has been well-regarded for its relaxant properties in the old world and the new, with a recent surge in popularity amongst holistic health communities and practitioners. The applications of CBD isolates and infused products are diverse—dependent upon factors such as concentration, source of extraction, and mode of administration—with options from sublingual/edible to topical or transdermal introduction into the body. With the recent uptick in these natural and therapeutic remedies, a slew of diverse patient demographics have shifted their focus toward CBD treatment for a variety of conditions associated with chronic pain, heritable neuropathic disorders, and even certain forms of cancer. According to a survey-based study in the journal of Current Oncology, which examined incidences of cannabis use by cancer patients, 71% of respondents reported effective relief from one or more symptoms after the introduction of cannabinoids.
The two most prevalent cannabinoids isolated from the cannabis plant are cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). While both of these cannabinoids target the endocannabinoid system of the body (ECS)—an innate network of receptors that enables the effects of cannabinoids on mental and bodily processes—the most effective of the two for specific symptom relief has proven to be CBD, with THC associated with more psychoactive effects. The application of CBD allows patients to reap the benefits of its analgesic, anti inflammatory, and pro-apoptotic properties.
The efficacy of CBD for the treatment of pain within a holistically supplemented cancer treatment plan ultimately depends on the dose administered, as well as the severity of the patient’s presentation. However, in combination with other prescribed pain management medications, CBD can greatly assist the relief of both muscular discomfort and neuropathy. Another comfort provided by CBD is the appetite stimulation often accompanied with administration of concentrated CBD extracts. This can be a highly valuable tool for a patient struggling to meet nutritional needs due to cachexia as a result of chemotherapy or nausea from concurrent medications. Nutritional support, in conjunction with pain relief and a more manageable continuation throughout the treatment plan may ultimately improve outcomes for many patients.
Another valuable property of CBD is its pro-apoptotic capacity, a benefit which is currently undergoing extensive research. Apoptosis is the medical term for programmed cell death. Some cells undergo apoptosis frequently and rapidly (such as the cells of the epidermis, which are constantly dying, shedding and being replaced). Cancer cells, however, are cells whose apoptotic mechanisms are inhibited and are also undergoing uncontrolled cell division, causing masses of cells (tumors) to form and metastasize or spread throughout the body systems. Pro-apoptotic agents may prove to be critical tools in the suppression of cancer cells and, consequently, metastasis to lymphatic systems. The apoptosis of cancer cells would also result in the gradual reduction of the size of observable tumors. This alone would greatly improve the outcomes of most forms of cancer, as partial remission is formally characterized by a reduction in tumor size.
Capitol Organics is proud to provide high-quality, medical grade CBD isolates and infused topicals for use in treating a wide range of symptoms, including moderate to severe pain and nausea. Our THC-free CBD products focus solely on therapeutic relief for the body, and are safe for administration alongside pre-existing medications, and in the context of a treatment plan. For more information about our scientifically-backed CBD products, please visit our website.